Case-Control Study of a Novel Test for the Early Detection of Hepatocellular Carcinoma in at-risk Patients with Cirrhosis

Sponsor:
Curve Biosciences
Sponsor Study ID:
CRV-HCC-001
CTO #:
104356
NCT Number:
NCT99999999
Phase:
N/A
Protocol Type:
Screening
Age Group:
Adults
Disease Sites:
Liver
Study Objectives:
To determine the diagnostic accuracy of the novel Hepatocellular Carcinoma (HCC) Test developed by Curve Biosciences in terms of area under the receiver operating characteristic curve (AUROC), sensitivity, and specificity for the differentiation of patients with HCC from those without HCC in the at-risk population.
eConsent:
Not available
Study Documents:
Open Study Documents
(MUSC NetID required for document access)

For more information about this trial please contact the study team:

Trial opened at the following institutions:

Medical University of South Carolina